【摘要】： 大鼠腳掌注射完全弗氏佐劑(CFA)是一個(gè)被廣泛應(yīng)用的慢性炎性痛模型。在注射CFA后,動(dòng)物會(huì)迅速出現(xiàn)一個(gè)對(duì)熱刺激或機(jī)械刺激敏感的狀態(tài),表現(xiàn)為傷害性熱刺激引起的縮足反射潛伏期明顯縮短。由CFA導(dǎo)致的熱痛敏的高峰出現(xiàn)在注射后2-6小時(shí),并持續(xù)約2周左右。近年來的研究表明,脊髓膠質(zhì)細(xì)胞的激活在慢性痛的發(fā)生發(fā)展中發(fā)揮重要作用。在此過程,脊髓小膠質(zhì)細(xì)胞與星形膠質(zhì)細(xì)胞均有激活,并且小膠質(zhì)細(xì)胞在慢性痛敏的產(chǎn)生和誘導(dǎo)過程發(fā)揮重要作用,而星形膠質(zhì)細(xì)胞對(duì)于痛敏狀態(tài)的持續(xù)維持發(fā)揮作用。本研究室之前的觀察已證實(shí),外周第III組代謝型谷氨酸受體(mGluRs)在Formalin引起的急性炎性痛中發(fā)揮重要作用。由于另外的研究表明,脊髓膠質(zhì)細(xì)胞上同樣表達(dá)第III組mGluRs。本實(shí)驗(yàn)在大鼠腳掌注射CFA的基礎(chǔ)上,通過痛行為觀察(熱輻射刺激縮足反射潛伏期,PWL)、對(duì)脊髓星形膠質(zhì)細(xì)胞活化標(biāo)志物(GFAP)的免疫組化檢測(cè),結(jié)合外周注射第III組mGluRs激動(dòng)劑L-SOP,觀察外周第III組mGluRs在CFA所致熱痛敏及脊髓膠質(zhì)細(xì)胞活化中的作用。 實(shí)驗(yàn)在Sprague-Dawley雄性大鼠(90~100g)進(jìn)行,分為免疫組化實(shí)驗(yàn)和行為學(xué)觀察兩部分。60只大鼠分為兩組,第一組(予先給藥組)在CFA注射前15分鐘預(yù)先腳掌皮下給予第III組mGluRs的激動(dòng)劑L-SOP (250nmol),然后在CFA注射后的第1,2,3,4天分別重復(fù)給予同樣劑量的L-SOP。第二組(晚期給藥組)在給予CFA后的第4,5,6,7,8天分別重復(fù)給予相同劑量的L-SOP。兩組均在CFA注射后8小時(shí),1天、4天,8天,14天隨機(jī)選擇六只大鼠,進(jìn)行痛行為學(xué)觀察及脊髓星形膠質(zhì)細(xì)胞激活標(biāo)志物GFAP的免疫組化檢測(cè),分別對(duì)比背角兩側(cè)星形膠質(zhì)細(xì)胞的免疫組化反應(yīng),進(jìn)行圖像分析及統(tǒng)計(jì)學(xué)處理。 行為學(xué)觀察結(jié)果顯示,大鼠足掌給予CFA(1:1,50μl)后,動(dòng)物即刻出現(xiàn)痛行為反應(yīng),表現(xiàn)為PWL的縮短,4-8小時(shí)出現(xiàn)了熱痛敏反應(yīng)的高峰,觀察至第14天仍未完全恢復(fù)正常。在早期給藥組外周應(yīng)用L-SOP(250nmol)后,PWL明顯延長,與對(duì)照側(cè)相比,8h、1天、4天具有顯著性差異(P0.05),在晚期給藥組,PWL的延長在4天、8天與對(duì)照側(cè)相比有統(tǒng)計(jì)學(xué)差異(P0.05)。 免疫組化結(jié)果顯示,大鼠足掌給予CFA后,脊髓背角星形膠質(zhì)細(xì)胞在4天后表達(dá)增加,并持續(xù)到14天以后。在外周早期給予L-SOP后,星形膠質(zhì)細(xì)胞GFAP陽性表達(dá)明顯降低,在4、8、14天GFAP陽性表達(dá)的抑制率分別為18.61%、24.45%、20.54%,與對(duì)照側(cè)相比均有顯著性差異(P0.05)。在晚期給藥組,GFAP陽性表達(dá)第8天時(shí)在用藥側(cè)有
[Abstract]:Rat foot injection of complete Freund's adjuvant (CFA) is a widely used chronic inflammatory pain model. After the injection of CFA, the animal will quickly appear to be sensitive to thermal or mechanical stimulation, showing that the latent period of foot contraction reflex induced by nociceptive heat stimulation is obviously shortened. The peak of heat sensitivity caused by CFA appears 2-6 hours after injection and lasts about 2 weeks. Recent studies have shown that the activation of glial cells plays an important role in the development of chronic pain. In this process, both microglia and astrocytes are activated, and microglia play an important role in the generation and induction of chronic hyperalgesia, while astrocytes play an important role in the sustained maintenance of hyperalgesia. Previous observations in this laboratory have confirmed that the metabolic glutamate receptor (mGluRs) in peripheral III group plays an important role in acute inflammatory pain induced by Formalin. As a result of other studies, the same expression of mGluRs. in group III was found in glial cells of the spinal cord. On the basis of the injection of CFA to the foot of rats, the pain behavior was observed by observing the immunocytochemistry of (GFAP), the activation marker of astrocytes of spinal cord, by, PWL), in latent period of reflex induced by thermal radiation. Combined with peripheral injection of L-SOP, mGluRs agonist L-SOP in III group, the role of mGluRs in CFA induced hyperthermia and activation of spinal glial cells in peripheral III group was observed. The experiment was carried out in male Sprague-Dawley rats (90g / 100g) and was divided into two parts: immunohistochemical experiment and behavioral observation. 60 rats were divided into two groups. The first group (pre-administration group) was subcutaneously given L-SOP (250nmol), the agonist of mGluRs in the III group, 15 minutes before the injection of CFA, and then repeated the same dose of L-SOP at 34th day after CFA injection. The second group (late administration group) was treated with the same dose of L-SOP on the 4th day, 5th day and 7th day after CFA. Six rats were randomly selected at 8 hours, 1 day, 4 days, 8 days and 14 days after CFA injection to observe the pain behavior and detect the GFAP of astrocyte activation marker in spinal cord. The immunohistochemical reaction of astrocytes on both sides of the dorsal horn was compared, and the image analysis and statistical analysis were carried out. The results of behavioral observation showed that after CFA (1: 1: 50 渭 l) was given to the palmar of the foot, the pain behavior of the rats appeared immediately, which was manifested by the shortening of the PWL, the peak of the thermal pain sensitivity at 4-8 hours, and the observation on the 14th day did not return to normal completely. In the early administration group, PWL was significantly prolonged after peripheral administration of L-SOP (250nmol). Compared with the control group, there was a significant difference at 8 h and 4 days (P0.05). In the late administration group, the PWL was prolonged at 4 days. There was statistical difference between 8 days and control side (P0.05). Immunohistochemical results showed that the expression of astrocytes in spinal dorsal horn increased 4 days after CFA and lasted for 14 days. After early L-SOP administration, the positive expression of GFAP in astrocytes decreased significantly, and the inhibitory rates of GFAP positive expression were 18.61 ~ 24.45 and 20.54 on day 14, respectively. Compared with the control side, there were significant differences (P0.05). In the advanced administration group, the positive expression of GFAP was found on the side of the drug on the 8th day.
【學(xué)位授予單位】：山西醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2006
【分類號(hào)】：R33

【共引文獻(xiàn)】

相關(guān)期刊論文 前7條

1 堯新華;肖珍科;周樸;王保;陳陳燕;陳鳳英;郭芬芬;;大鼠鞘內(nèi)腺苷同類物CHA抗神經(jīng)病理性疼痛作用[J];廣東醫(yī)學(xué);2007年12期

2 孫曉峰;K~+通道調(diào)控劑對(duì)與鎮(zhèn)痛有關(guān)藥物的抗傷害性感受的影響[J];國外醫(yī)學(xué).麻醉學(xué)與復(fù)蘇分冊(cè);2003年02期

3 朱顯武;感覺神經(jīng)元的傳入和“傳出”功能[J];現(xiàn)代電生理學(xué)雜志;2005年02期

4 王金,麻海春,劉軍,馮春生,盧寶順,趙華;脊髓水平三磷酸腺苷敏感型鉀離子通道調(diào)控劑對(duì)腺苷鎮(zhèn)痛作用的調(diào)節(jié)[J];中國臨床康復(fù);2005年21期

5 ;Effects of adenosine agonist R-phenylisopropyl-adenosine on halothane anesthesia and antinociception in rats[J];Acta Pharmacologica Sinica;2005年02期

6 李放,張凱莉,朱藝,徐一鳴,范振華,沈麗英,屠丹云,胡永善;膝關(guān)節(jié)骨關(guān)節(jié)炎的屈伸膝肌存在脊髓水平的選擇性抑制[J];中華物理醫(yī)學(xué)與康復(fù)雜志;2001年02期

7 馮春生;岳云;麻海春;王云;張永謙;;腦干網(wǎng)狀結(jié)構(gòu)內(nèi)注射腺苷A_1受體激動(dòng)劑對(duì)大鼠的鎮(zhèn)痛作用[J];中華麻醉學(xué)雜志;2006年07期

相關(guān)博士學(xué)位論文 前4條

1 汪福洲;脊髓MIF介導(dǎo)疼痛病理發(fā)生的分子機(jī)制研究[D];南京大學(xué);2011年

2 李先春;青陽參總甙抗癲癇作用的分子機(jī)理研究[D];華東師范大學(xué);2005年

3 李志松;κ阿片受體激動(dòng)劑U50488對(duì)未分化PC12細(xì)胞鉀通道的調(diào)節(jié)作用及其機(jī)理的初步探討[D];中國協(xié)和醫(yī)科大學(xué);2006年

4 李慶霞;NG108-15細(xì)胞阿片受體對(duì)延遲整流鉀通道的調(diào)節(jié)作用及機(jī)理研究[D];中國協(xié)和醫(yī)科大學(xué);1997年

相關(guān)碩士學(xué)位論文 前6條

1 王超;ATP敏感鉀通道的激活對(duì)傷害性疼痛行為以及對(duì)DRG的超敏反應(yīng)的拮抗作用[D];河北醫(yī)科大學(xué);2011年

2 吳煥兵;K_ATP通道在慢性神經(jīng)病理性疼痛和開胸術(shù)后慢性疼痛所致痛覺超敏中的作用[D];華中科技大學(xué);2010年

3 魏華;外周5-羥色胺2A受體在角叉菜膠誘發(fā)的痛敏和炎癥中的作用[D];福建師范大學(xué);2006年

4 陶谷揚(yáng);大鼠骨關(guān)節(jié)損傷炎性疼痛分子機(jī)制的探討[D];湖南師范大學(xué);2009年

5 郭超;Ⅰ型糖尿病改變了內(nèi)嗎啡肽對(duì)小鼠結(jié)腸收縮特性的影響[D];蘭州大學(xué);2009年

6 何娟;帕瑞昔布鈉復(fù)合舒芬太尼用于胸科術(shù)后患者靜脈自控鎮(zhèn)痛的觀察[D];中國醫(yī)科大學(xué);2010年

，

本文編號(hào)：2348480